SIR advocates on behalf of its members and interventional radiology before Congress, insurance carriers and other key decision-makers. The society also reaches around the world and out to partners across corporate, public and private sectors to ensure the story of interventional radiology is spread through a range of communication channels.
SIR signs onto letter to Congress about physician inclusion in Congressional stimulus legislation
SIR joined the American Medical Association (AMA) and other medical specialty societies to send a letter to Congress on March 25, 2020. To ensure Congress includes physicians in all COVID-19 stimulus relief packages, the letter expressed the need to recognize that physicians and practices are feeling the fiscal impact of canceled procedures, reduced patient access, and potentially unpaid telehealth consultations.
SIR submits comments to FDA for PTA and specialty catheters-premarket notifications
On March 12, 2020, SIR submitted comments to the FDA about Peripheral Percutaneous Transluminal Angioplasty (PTA) and Specialty Catheters-Premarket Notification (510(k)) Submissions. SIR urged the FDA to consider including language in the final guidance addressing the issue of patient safety as it relates to drug-coated balloons and stents.
HHS releases three-party study about sepsis
In February 2020, HHS released a three-part study that US hospitals saw a 40% increase in the rate of Medicare beneficiaries hospitalized with sepsis over the past seven years and in 2018 had an estimated cost to Medicare of more than $41.5 billion. According to the CMS Administrator Seema Verma, “this groundbreaking study sheds new light on the sepsis-related challenges faced by patients, providers, and taxpayers alike.”
CMS and ONC release finalized interoperability rule
On March 9th, 2020, the Centers for Medicare and Medicaid Services (CMS) and the Office of the National Coordinator of Health Information Technology (ONC) released a final version of its long-awaited interoperability rule. The rule addresses health information sharing between patients and providers while imposing guidelines to keep that information private and secure.
The final rule requires CMS to publicly report clinicians, hospitals, and critical access hospitals (CAHs) that may be information blocking. Knowing which providers may be information blocking can help patients choose providers who are more likely to support electronic access to their health information.
SIR signed onto a Physician Clinical Registry Coalition (PCRC) letter about this proposed rule in March 2019. The letter expressed a need for CMS to address information blocking and improve the flow of information between hospital EHRs, LISs, imaging systems, and registries.
SIR signs on to prior authorization letter to CMS
SIR joined other medical specialty groups and the American Medical Association (AMA) last September to communicate with CMS to express concern about the overuse of sole-source solutions to address the prior authorization issue. On February 21, 2020, the American Medical Association received a response from CMS. SIR will continue to engage with the Administration to promote broad prior authorization reform.
Surprise billing legislative activity update
The House of Representatives Education and Labor Committee marked up H.R.5800, the“ Ban Surprise Billing Act ”on Feb. 11and the House Ways and Means Committee marked up H.R. 5826, the “ Consumer Protections Against Surprise Medical Bills Act ” on Feb.12.
The House Energy and Commerce Committee and the Senate are still working on their versions of surprise billing legislation. One main issue in the surprise billing debate is whether to use benchmark payment rates or independent dispute resolution (IDR). The Ways and Means Committee bill allows IDR after a thirty-day negotiation period and uses the median in-network rate as the starting point for mediation. The White House prefers to avoid the IDR method because of potential increases in health care costs. Congress wants to add surprise billing to the Medicare extenders package before the May 22nd deadline.
FDA Nomination Requests
The Food and Drug Administration (FDA) posted the following requests for FDA Advisory Board and Standard Committee nominations:
All nominations for membership should be submitted electronically by logging into the FDA Advisory Nomination Portal at or by mail to Advisory Committee Oversight and Management Staff, Food and Drug Administration, 10903 New Hampshire Ave., Bldg. 32, Rm. 5103, Silver Spring, MD 20993-0002. Information about becoming a member on an FDA advisory committee can also be obtained by visiting FDA's website.
If you are interested in applying for any of these FDA Advisory Committees, please contact Judi Buckalew, SIR Director of Government Relations at email@example.com for more information and/ or assistance. SIR needs to know if you intend to submit an application or submit comments to the FDA.
FDA Reclassifies Radiological and Medical Imaging Devices
The Food and Drug Administration (FDA) posted a series of notices on January 22, 2020, about reclassifying radiological and medical imaging devices from Class III to Class II. To learn more about each reclassification please select from the links below.
FDA seeks information about the use of radioactive drugs
The Food and Drug Administration (FDA) posted a notice in the Federal Register on January 20, 2020, seeking public comments on information collection requirements contained in regulations governing the use of radioactive drugs for basic informational research for FDA’s Radioactive Drug Research Committees. Public comment and data collection will be open until March 23, 2020.
SIR signs onto CSM letter about scope of practice implications for non-physician led health practices
SIR joined with the American Medical Association (AMA) to send a letter to CMS on January 16, 2020. The letter expresses concern with the far-reaching implications of CMS’ request for information regarding physician-led health care and the impact changes will have on state scope of practice laws.
Your voice in Washington, D.C.
The Society of Interventional Radiology's government relations and health policy staff members work to further the interests of society members by advocating on their behalf before Congress, regulatory and federal agencies and the White House.
SIR members play a vital role in this process. The government affairs section will guide you through our advocacy efforts and the major policy issues that affect the society.
SIRPAC is the Society of Interventional Radiology Political Action Committee, a nonpartisan body dedicated to supporting political candidates who may help advance SIR’s public policy mission and legislative initiatives. SIRPAC elevates the profile of interventional radiology, SIR and society members among representatives in Congress by enabling the society to better leverage its lobbying efforts in Washington, D.C.
Over 40 years ago, all-new categories of devices enabled clinical pioneers to attempt the first true, minimally invasive, interventional techniques and inaugurate a tradition of partnership in improving outcomes.
SIR collaborates today with commercial partners through multiple avenues to reveal innovations in clinical devices, pharmaceuticals and combination technologies. Our corporate programs work to provide opportunities to align businesses with minimally-invasive providers, advance healthcare capabilities and benefit the patients we serve together. Learn more about how we partner with industry.
SIR facilitates access to experts and resources to help news outlets report on minimally invasive, image-guided therapeutic treatments. Find our latest media statements, our media contacts and more in the SIR newsroom.
The Society of Interventional Radiology media relations staff works with members of the news media to facilitate access to many resources and helps reporters cover issues about minimally invasive, image-guided therapeutic treatments.
Our communications department staff:
From the impact of healthcare reform to patient relations, SIR provides tips and advice for real-world issues facing today's medical practices. SIR offers toolkists, standards, guidelines and other valuable resources to equip you for success in quality reimbursement and advocacy.Find practice resources
Developing a global specialty
SIR’s goal is to build a global network to support IR everywhere. Building relationships, identifying regional needs and creating regional programmatic opportunities.
Partnership with industry can improve outcomes
Many businesses provide tools and services critical to the delivery of healthcare. Discover how companies can collaborate more closely with the society, engage better with the interventional radiology community and help make SIR’s mission possible.Meet CAP
Advance IR through advocacy
A donation to SIRPAC allows SIR to build relationships with key members of the House and Senate and their staffs to advance IR through legislation that promotes patient access to IR services.Donate now
The SIR International Scholars Program enables physicians within 10 years of completion of training, who are practicing outside North America, an opportunity to attend the SIR Annual Scientific Meeting. Offering physicians from other nations a chance to train and learn from their peers means that they can return to their countries to teach and enhance patient care. The program fosters professional networking through meeting participation, focused programming and optional observerships before or after annual meeting.